Yes, both Novo Nordisk (Ozempic, Wegovy) and Eli Lilly (Mounjaro, Zepbound) offer patient assistance programs for eligible patients. Novo Nordisk's Patient Assistance Program provides free medication to uninsured patients who meet income criteria (typically up to 400% of the federal poverty level). They also offer a savings card for commercially insured patients that can reduce copays to as low as $25 per month.
Eli Lilly offers similar programs for Mounjaro and Zepbound, including copay assistance cards and patient support programs. However, these programs generally cannot be used with Medicare or Medicaid. Some independent nonprofit organizations also offer assistance programs that may help bridge coverage gaps for qualifying patients.
Find a qualified GLP-1 provider
Compare pricing, clinical oversight, and patient reviews across verified telehealth programs and local clinics.
Compare Providers →Still have questions?
A qualified GLP-1 provider can give you personalized answers based on your medical history and goals.
Get answers to your GLP-1 questions
Weekly updates with the latest research, pricing changes, and expert guidance — delivered to your inbox.
No spam. Unsubscribe anytime.
Ready to start your GLP-1 journey?
Compare verified providers on pricing, medication sourcing, clinical oversight, and patient reviews — all in one place.